Christian Acemah, M.S., is executive secretary of the Uganda National Academy of Sciences (UNAS), where he is the chief executive officer of the UNAS secretariat and leads on all strategic, programmatic, financial, and administrative issues of the Academy. He is also Visiting Professor of African Studies at Quest University, Canada, where he teaches a range of courses on African development, politics, feminism, and the arts. Prior to joining UNAS in November 2015, Mr. Acemah was Director for Strategy and Program Development for the African Science Academy Development Initiative of the U.S. National Academies of Sciences, Engineering, and Medicine within the Institute of Medicine. Mr. Acemah has served as Executive Officer, Policy and Research, at the United Nations Children’s Fund (UNICEF) within the Gavi, the Vaccine Alliance Secretariat in Geneva, Switzerland. In that role, he was a junior advisor to the CEO of Gavi. Prior to that, he worked in the Sudan-Uganda program of the Lutheran World Federation/Department for World Service on livelihoods projects and HIV/AIDS advocacy, monitoring, and evaluation. He has also been a development economics researcher for Dr. Callisto Madavo, former Vice President of the World Bank, and development anthropology researcher for Prof. Gwendolyn Mikell at Georgetown University. He received his first degree in mathematics and philosophy from St. John’s College in Santa Fe, New Mexico, and master of science in international development economics and strategy from Georgetown University in Washington, DC.
Ann Aerts, M.D., M.P.H., DTM, has been head of the Novartis Foundation since January 2013. The Novartis Foundation has the challenging goals of expanding access to quality healthcare and eliminating diseases such as leprosy and malaria. Before her current role, Dr. Aerts was Franchise Medical Director Critical Care for Novartis Pharma in Basel and Therapeutic Area Head Cardiovascular and Metabolism in Novartis Pharma Belgium. Prior to joining Novartis, she served as Director of the Lung and Tuberculosis Association in Belgium, as Head of the Health Services Department of the International Committee of the Red Cross (ICRC) in Geneva and was Health Coordinator for the ICRC in several countries.
Dr. Aerts holds a doctor of medicine and a master of public health from the University of Leuven, Belgium, as well as a degree in tropical medicine from the Institute of Tropical Medicine in Antwerp, Belgium. Dr. Aerts is a member of the Advisory Boards of the Global Health Group of University of California, San Francisco (UCSF), the OECD Network of Foundations Working in Development (NetFWD), a Member of the International Telecommunication Union/United Nations Educational, Scientific and Cultural Organization (ITU/UNESCO) Broadband Commission for Sustainable Development and of the Governing Council of the Technology Bank for the Least Developed Countries.
Angela Akol, M.D., M.A., is an international health practitioner, with 14 years’ experience developing and leading complex integrated development programs in developing countries. Dr. Akol’s cross-cutting skills in program leadership and management, public relations, communications, negotiation, and capacity building are expertly applied in her role as Uganda Country Director for FHI 360. Dr. Akol provides overall leadership for FHI 360’s Uganda portfolio, which includes overall oversight of program implementation, personnel management, and financial monitoring for six U.S. Agency for International Development (USAID)-funded projects. Before joining FHI 360, Dr. Akol worked for the government of Uganda, responsible for the design and management of components of the government of Uganda/United Nations Population Fund (UNFPA) Country Population Program, and coordinating civil society implementers. She began her career as a medical officer at Mulago Hospital, in Kampala, Uganda.
Simon Bland, M.S., CBE, joined UNAIDS in August 2013 as its director in New York. Prior to joining UNAIDS, Mr. Bland was a senior civil servant in the United Kingdom’s Department for International Development (DfID) and, most recently, headed its Global Funds Department. In this role he was responsible for the United Kingdom’s policies, programmes,
financial management, and shareholder relations with Global Funds and Innovative Finance in health and education. He represented the United Kingdom on the Boards of the Global Fund to Fight AIDS, Tuberculosis and Malaria; Gavi, the Vaccine Alliance; Unitaid, and the Global Partnership for Education. From September 2011 to June 2013, Mr. Bland was chair of the Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria and oversaw a substantial transformation culminating with the introduction of its new funding model and strengthened partnership approach. Mr. Bland’s early background was in marine sciences and natural resources management, later branching out into development economics and management. He has spent most of the past 30 years working in developing countries in Africa, Asia, and the Pacific. He has led DfID country programs in Kenya, Russia, Somalia, and Ukraine before moving to Geneva to work on global health, education, and humanitarian affairs. Mr. Bland was made a Commander of the British Empire in the Queen’s Birthday Honours list in 2013 for service to Global Health.
Jeff Blander, Sc.D., M.S., serves as the chief innovation officer for the Office of the Global AIDS Coordinator and Health Diplomacy (OGAC). In this role, Dr. Blander supports the Chief Strategy Officer and OGAC Front Office in the provision of overall leadership, guidance, and programs for cultivating, incubating, and scaling high impact innovation strategies and initiatives for The President’s Emergency Plan for AIDS Relief (PEPFAR). Prior to joining OGAC, Dr. Blander co-founded and served as the president of the Bienmoyo Foundation, a nonprofit organization providing advisory services for the design of high-impact strategic public–private partnerships focused on the adoption of point of care diagnostic technologies and integration of public and private provider networks to address the double burden of infectious and noncommunicable diseases. He held dual research appointments at the Brigham and Women’s Hospital and Harvard School of Public Health as well as served as the director for courses he cofounded on global health practice innovation, business strategy, and medical technology in the Division of Health Science & Technology at Harvard Medical School and the Massachusetts Institute of Technology. Dr. Blander received his doctorate and two master’s degrees from Harvard University and his bachelor of science from the Wharton School of the University of Pennsylvania.
Jo Ivey Boufford, M.D., is president of The New York Academy of Medicine. Dr. Boufford is Professor of Public Service, Health Policy and Management, at the Robert F. Wagner Graduate School of Public Service and Clinical Professor of Pediatrics at New York University School of Medicine. She served as Dean of the Robert F. Wagner Graduate School
of Public Service at New York University from June 1997 to November 2002. Prior to that, she served as Principal Deputy Assistant Secretary for Health in the U.S. Department of Health and Human Services (HHS) from November 1993 to January 1997, and as Acting Assistant Secretary from January 1997 to May 1997. While at HHS, she served as the U.S. representative on the Executive Board of the World Health Organization (WHO) from 1994 to 1997. From May 1991 to September 1993, Dr. Boufford served as Director of the King’s Fund College, London. The King’s Fund is a royal charity dedicated to the support of health and social services in London and the United Kingdom. She served as President of the New York City Health and Hospitals Corporation (HHC), the largest municipal system in the United States, from December 1985 until October 1989. Dr. Boufford was awarded a Robert Wood Johnson Health Policy Fellowship at the Institute of Medicine in Washington, DC, for 1979–1980. She served as a member of the National Council on Graduate Medical Education and the National Advisory Council for the Agency for Healthcare Research and Quality from 1997–2002. She currently serves on the boards of the United Hospital Fund, the Primary Care Development Corporation, and Public Health Solutions (formerly MHRA). She was President of the National Association of Schools of Public Affairs and Administration in 2002–2003. She was elected to membership in the National Academy of Medicine in 1992 and is a member of the National Academies of Sciences, Engineering, and Medicine’s Executive Council, Board on Global Health, and Board on African Science Academy Development. She was elected to serve a second 4-year term as the Foreign Secretary of the Institute of Medicine beginning July 1, 2010. She received Honorary Doctorate of Science degree from the State University of New York, Brooklyn, May 1992; New York Medical College, May 2007; Pace University, May 2011; and Toledo University, June 2012. She was elected a Fellow of the National Academy of Public Administration in 2005. She has been a Fellow of The New York Academy of Medicine since 1988 and a Trustee since 2004. Dr. Boufford attended Wellesley College for 2 years and received her B.A. in psychology, magna cum laude, from the University of Michigan, and her M.D., with distinction, from the University of Michigan Medical School. She is Board Certified in pediatrics.
Chris Bruce is the director of international sales and consulting services at British Telecom (BT) Global Services. He is focused on developing mobility strategies for BT and for its international telecommunications clients across Asia, Middle East, Africa, and the Americas. He is also co-chair of the Wireless Broadband Alliance and a mentor with the Cognicity Challenge for IoT (Internet of Things) Smart Cities Start-Ups (www.cognicity.london). Previously, Mr. Bruce was CEO of BT Openzone, provider of the
BT public Wi-Fi service, where he led the deployment of more than 5 million Wi-Fi hotspots. He also developed partnerships with mobile operators for offload services and with venue partners in the hospitality and travel sectors. Mr. Bruce led the BT negotiations with Locog to provide public Wi-Fi for the London 2012 Olympics across nine venues and public areas across the Olympic Park. Mr. Bruce has more than 25 years of international experience in the telecommunications industry in a range of general management, product, marketing, and sales channel roles. Prior to BT, he held roles with Ericsson, Ascom, and CASE Communications. Mr. Bruce has been responsible for business growth in the international data communications, mobile, Internet hosting, global voice, and wireless broadband sectors.
Paul Clyde, Ph.D., is president of the William Davidson Institute at the University of Michigan, and the Tom Lantos Professor of Business Economics and Public Policy at the Ross School of Business. Dr. Clyde’s recent work has focused on health care in emerging markets with an emphasis on health care delivery. Over the past 15 years he has advised or run 70 health care engagements in 12 different low- or middle-income countries. In the process, he has worked with small start-up health care corporations interested in serving these markets, and faculty from the medical school, nursing school, and law school in developing a financially self-sustainable health care business model. Prior to joining the university, Dr. Clyde was an economist at the Antitrust Division of the U.S. Department of Justice and a consultant with National Economic Research Associates. While at the Antitrust Division, he advised the governments of many transition economies on their competition laws and natural monopoly laws. In 1993, he lived in Slovakia and served as an economic advisor to the governments of the Czech Republic and Slovakia on competition policy. He has been recognized as Teacher of the Year and has been awarded the Andy Andrews Distinguished Service Award. He has published articles in a number of journals, including the Journal of Finance, Managerial and Decision Economics, and Economic Inquiry. He received his Ph.D. in economics from the University of California, Los Angeles, and his B.S. in business from Indiana University.
Gary Cohen, M.B.A., is executive vice president and president, Global Health and Development, at Becton, Dickinson and Company (BD), a global medical technology company operating in 150 countries with more than 45,000 employees. He joined BD in 1983 and has served as an executive officer since 1996. Mr. Cohen is also acting chief executive officer of GBCHealth; a board director of the Perrigo Company, CDC Foundation, the U.S. Fund for UNICEF; and board chair/founder of Together for Girls,
a partnership of five United Nations (UN) agencies, the governments of the United States and Canada, and other partners to end violence against children, particularly sexual violence against girls. He is a vice chair of the Millennium Development Goal (MDG) Health Alliance and recently served on the UN Commission on Life Saving Commodities for Women and Children. He is also a member of the UN Secretary-General’s Network of Engaged Men Leaders. Mr. Cohen and BD extensively engage in cross-sector collaboration to address unmet health needs globally, including among high-disease burden, low-resource populations, using various methods such as social investing, corporate social responsibility, and shared value creation. He serves as a speaker and advocate on advancing health and human rights in forums including the United Nations, World Economic Forum, and the Clinton Global Initiative. He has been honored by Medical Education for South African Blacks, B’nai B’rith International, the U.S. Fund for UNICEF, the Nyumbani Home for orphaned HIV-positive children, the American Jewish Committee, and the Dikembe Mutombo Foundation. Mr. Cohen holds a B.A. and an M.B.A. from Rutgers University and previously served on the university’s board of trustees.
Bruce Compton is senior director of international outreach for the Catholic Health Association (CHA) of the United States. He is based in the association’s St. Louis office. Mr. Compton is responsible for assisting and supporting CHA-member organizations in their outreach activities in the developing world. His duties include facilitating collaboration among CHA-member organizations and others, seeking to enhance the impact of international ministries. Additionally, he is responsible for education regarding international outreach issues and encouraging CHA members’ participation in various activities of international ministry. Compton lived in Haiti from 2000 to 2002, and he continued to work in support of health missions in the developing world after he returned to the United States. He did so in his capacity as founding president and chief executive of the Hospital Sisters Mission Outreach based in Springfield, Illinois, a ministry organization bringing surplus medical supplies from Midwest hospitals to medical missions in the developing world.
Pedro Conceição, Ph.D., has been director of strategic policy at the United Nations Development Programme’s (UNDP’s) Bureau for Policy and Programme Support since October 2014. Before that, he was chief-economist and head of the Strategic Advisory Unit at UNDP’s Regional Bureau for Africa (from December 1, 2009). Prior to this, Mr. Conceição was director of the Office of Development Studies (ODS) from March 2007 to November 2009, and deputy director of ODS, from October 2001 to
February 2007. His work on financing for development and on global public goods was published by Oxford University Press in books he co-edited (The New Public Finance: Responding to Global Challenges, 2006; Providing Global Public Goods: Managing Globalization, 2003). He co-edited several books on the economics of innovation and technological change, including Innovation, Competence Building, and Social Cohesion in Europe—Towards a Learning Society (Edward Elgar, 2002) and Knowledge for Inclusive Development (Quorum Books, 2001). Mr. Conceição has published, among others journals, in the African Development Review, Review of Development Economics, Eastern Economic Journal, Ecological Economics, Environmental Economics and Policy Studies, and Technological Forecasting and Social Change. Prior to coming to UNDP, he was an assistant professor at the Instituto Superior Técnico, Lisbon, Portugal, teaching and researching on science, technology, and innovation policy. Mr. Conceição is a Portuguese national and holds degrees in physics from Instituto Superior Técnico and in economics from the Technical University of Lisbon and a Ph.D. in public policy from the Lyndon B. Johnson School of Public Affairs at The University of Texas at Austin, with a Fulbright scholarship.
Mariarosa Cutillo, a national of Italy, has recently undertaken the role of chief of the Strategic Partnerships Branch, within the Division of Communications and Strategic Partnerships of the United Nations Population Fund (UNFPA). She brings with her more than 20 years of professional experience, working for the private sector. Before joining UNFPA, she was the head of corporate social responsibility at Benetton Group, as well as president and chief executive officer of Benetton’s UNHATE Foundation. She has served as director of Valore Sociale per l’Impresa Responsabile (a multistakeholder corporate social responsibility organization). On issues relating to corporate sustainability, she has served as a legal expert for various institutions. She has also worked extensively for the international nongovernmental organization Mani Tese. Ms. Cutillo was also a professor in international law cases in the Faculty of Law of the University of Milan-Bicocca and senior lecturer at the Catholic University of Milan, Faculties of Law and Political and Social Sciences. She obtained a degree in advanced international law from the Faculty of Law of the Catholic University of Milan in 1995. She has postgraduate specializations in human rights and in business administration, with a specific focus on social and environmental sustainability.
Kate Dodson, MALAS, is the vice president for Global Health Strategy at the United Nations (UN) Foundation. In this role, Ms. Dodson works to ensure that the UN Foundation is delivering on its commitments to address the health-related Sustainable Development Goals, and builds
synergies with UN agencies and other key multilateral partners. Previously, she spent several years as the UN Foundation’s Director of Global Health, and has also served as Executive Director of Program Integration, which focused on cross-department and cross-issue collaboration. Ms. Dodson spent her first 5 years at UNF in the biodiversity/sustainable development program in various positions, including deputy director of sustainable development. Ms. Dodson has many years of experience working on global development and has traveled, worked, and studied in several countries. She has a master’s degree with distinction from Georgetown University’s School of Foreign Service and a bachelor’s degree with departmental honors from Bates College in Maine.
Kevin Etter is director of the UPS Foundation Humanitarian Relief and Resilience Program and special advisor to Gavi, the Vaccine Alliance Health System and Immunization Strengthening Programs. Built on work over three decades with UPS (United Parcel Service), Mr. Etter is an internationally recognized thought leader in the field of logistics and supply chain service innovation. A few of his accomplishments to date include large aircraft fleet acquisition and integration projects; development of new services built through focusing on strategic mergers and acquisition activities; new service ideas and innovation for the pharmaceutical, medical device; and health products supply chain and security; and new ways of thinking about corporate social responsibility. Mr. Etter is a strong voice and advocate in the world of community service and corporate philanthropy, active both at home, in Europe, and at UPS. A current project with the UPS Foundation has him seconded (executive on loan) to Gavi, the Vaccine Alliance in Geneva, Switzerland. There, Mr. Etter is advising, consulting, and developing solutions supporting Gavi’s Supply Chain Strategy. He is also pioneering innovative models for public–private partnerships with Gavi, UN organizations, and other international nongovernmental organizations. Mr. Etter presented a TED Talk titled “I am the Donation” that features his work with Gavi and highlights the opportunity that our business communities have in moving beyond checkbook philanthropy to create real change in our world today.
Jeremy Farrar, OBE, FRCP, FRS, FMedSci, is director of the Wellcome Trust. Before joining Wellcome in October 2013, Dr. Farrar was director of the Oxford University Clinical Research Unit in Vietnam, where his research interests were infectious diseases, tropical health, and emerging infections. He has contributed to 500 peer-reviewed scientific papers and has served on several World Health Organization advisory committees. Dr. Farrar was appointed OBE in 2005 for services to tropical medicine, and he has been awarded the Memorial Medal and the Ho Chi Minh
City Medal by the government of Vietnam, the Frederick Murgatroyd Prize for Tropical Medicine by the Royal College Physicians, and the Bailey Ashford Award by the American Society for Tropical Medicine and Hygiene. He is a fellow of the Academy of Medical Sciences.
Kira Fortune, Ph.D., M.A., has worked more than 15 years in Africa, Asia, Europe, and Latin America in positions related to public health, gender, and social determinants of health. She spent 4 years working in the Department of Global Advocacy at the International Planned Parenthood Federation in London and then 3 years with UNICEF in Dar es Salaam, Tanzania, where she was responsible for the program on Prevention of Mother-to-Child Transmission of HIV. Dr. Fortune has extensive experience working with and within nongovernmental organizations (NGOs), academia, and in intergovernmental organizations focusing on gender mainstreaming, social determinants of health, Health in All Policies, as well as general public health issues. Prior to moving to Washington, DC, she coordinated the International Health Research Network in Denmark with the objective of translating research evidence into policy. In 2008 she joined the Pan American Health Organization, the regional office of the United Nations’ World Health Organization, where she is the Acting Chief for the Special Program on Sustainable Development and Health Equity. Dr. Fortune holds a master’s degree in anthropology, development, and gender as well as a doctorate in sociology on the challenge of gender mainstreaming for a contemporary NGO from the University of London, England. She also holds a master’s degree in international public health from Copenhagen University, Denmark.
Renuka Gadde, M.B.A., has 14 years of work experience with Becton, Dickinson and Company (BD), a medical devices and diagnostics company. In her current role, she works with international agencies, thought leaders, and governments to strengthen medical and clinical practices around the world. Her role focuses on reaching and creating access to the unserved and underserved populations in the developing and emerging markets. Prior to her current role, Ms. Gadde was leading the Emerging Markets Injection Safety platform at BD. During this period, she interacted with several international agencies and governments and played a key role in the formulation of safe injection policies that protect the patient and health care workers. She was also instrumental in developing unique product solutions specifically suited for the emerging markets and was the key contact for UNICEF supplies in Copenhagen and for driving programs and policies with UNICEF in New York. Her current focus is to establish appropriate policies and standards for safe blood collection and to drive public–private partnerships (PPPs) that improve practices
and conditions across a wide range of health initiatives such as HIV, cancer, and TB. As part of the Global Health team, Ms. Gadde has developed several key PPPs that improve clinical practices and build capabilities within countries. Key programs she has led include developing four partnerships with PEPFAR, with the International Council of Nurses, and UNICEF. All these partnerships aim to strengthen health systems and improve health care capacity across sub-Saharan Africa. Ms. Gadde has extensively traveled across many of the developing and emerging markets and has a deep understanding of the challenges in these markets.
Tim Genders is the chief operating officer of Project Isizwe. Project Isizwe has deployed the largest free Wi-Fi network in Africa in the Tshwane Municipality, Gauteng, South Africa. Mr. Genders graduated from Oxford University in 1989 with a first-class honors degree in engineering science. Mr. Genders came to South Africa in 1994 and set up an information technology consulting business with Matthew Blewett. In 2001 they merged with Benjamin and Isaac Mophatlane to become the leading Microsoft reseller Business Connexion. In 2006, after the merger with Comparex, he left Business Connexion to start a nongovernmental organization (NGO) with Marcus McGlivary called Africaid. Africaid uses football to develop HIV prevention skills in young adolescents. Africaid is making a major impact at Edendale hospital in a unique partnership with the Department of Health and has sponsors in FIFA, Liverpool FC, and the Charlize Theron Foundation. One year later in 2007, Mr. Genders formed Airband with Deon Brown and Gavin Blunt. Airband has grown to be one of the leading wireless players in KZN (KwaZulu-Natal) region. In November 2015 Mr. Genders sold Airband to HeroTel linking up with Alan Knott Craig, Junior, and Corne de Villiers. Airband has grown a further 50 percent during the past year while he stayed on as managing director. Mr. Genders is now following his passion for free Wi-Fi for Africa in Project Isizwe.
Allison Goldberg, Ph.D., has more than a decade of experience as a public health researcher and strategist working with leading companies, health providers, national and local governments, and nongovernmental organizations that share the goal of developing and applying evidence-based strategies in support of triple bottom line objectives and a focus on public health impact.
At the Anheuser-Busch (AB) InBev Foundation, she will support its president to oversee its overall operations and strategy, including the setup and management of the legal, administrative, and operational framework, and board of directors. Dr. Goldberg will also oversee priority initiatives, including the monitoring and evaluation activities related to the
Global Smart Drinking Goals (GSDGs) and related research; social norms program intervention development; selective public–private partnership efforts to reduce the harmful use of alcohol globally; and other opportunities that advance the Foundation’s overall mission and philosophy. As director of global corporate affairs, AB InBev for 3.5 years, Dr. Goldberg lead the design and implementation of initiatives that advance transformative public health policies related to responsible alcohol use, public safety, and global health. She co-lead the design and strategy for achieving the Global Smart Drinking Goals, AB InBev’s $1 billion commitment to reducing harmful alcohol use globally, and AB InBev’s engagement in the Together for Safer Roads initiative, a cross-industry coalition working to improve road safety globally. Dr. Goldberg represented AB InBev on the National Academies of Sciences, Engineering, and Medicine’s Forum on Public–Private Partnership for Global Health and Safety and managed AB InBev’s research and strategy development on global corporate reputation as well as its Global Advisory Council, an external board of global thought and business leaders, which provides insight and guidance to the company’s executive leadership on issues critical to the business and the world. Prior to joining AB InBev, Dr. Goldberg worked at the consulting firm Abt Associates where she helped manage U.S. and global health projects, including UKaid’s $250 million flagship program on improving Nigeria’s health system and a high-profile project in Malawi on health workforce performance. She has also held positions as a researcher at the International Center for AIDS Care and Treatment Programs (ICAP) at Columbia University and as a consultant in Johnson and Johnson’s Global Health Division, working with the Vice President of Global Health to promote public health policy programs. Dr. Goldberg has co-authored more than 40 academic and policy publications on topics ranging from infectious diseases, and health systems strengthening, to scaling up medical innovations, international health diplomacy and the social determinants of health. She frequently presents on these and other topics at high-level conferences throughout the world. Dr. Goldberg earned an interdisciplinary Ph.D. in public health and political science from Columbia University and a B.A. in political science from the University of Michigan. She is a 2015 Aspen Ideas Festival Scholar and holds an academic appointment as Lecturer at Columbia University.
Dan Hartman, M.D., joined the Bill & Melinda Gates Foundation in 2012 as the director of Integrated Development and leads a team that provides technical expertise in drug and diagnostic development. Under his leadership, Integrated Development works closely with the foundation’s disease strategy teams to manage product pipelines through clinical trials by providing state of the art input in the areas of quantitative
sciences/pharmacology, chemical manufacturing, and regulatory strategy. Integrated Development also manages investments in a variety of areas that will benefit numerous foundation strategies most notably in the areas of regulatory systems, pharmacology focused model based drug development, big data programs, novel formulations (including pediatrics) and low-cost manufacturing. In August 2016, Dr. Hartman was also named director of the Malaria Program Strategy Team with a focus on malaria eradication. In 2016, Dr. Hartman was also named an advisor to the National Center for the Advancement of Translational Sciences and the Cures Acceleration Network of the National Institutes of Health (USA) and is incoming president-elect of the American Society of Clinical Pharmacology and Therapeutics effective March 2017. Dr. Hartman has extensive management and pharmaceutical experience and joined the foundation after 4 years as president and CEO of Great Lakes Development Inc., a consulting company providing strategic and operational support for early drug development projects. Previously, Dr. Hartman served as senior vice president of product development at deCODE genetics, executive director of Pfizer Global Research and Development, vice president of global clinical development at Esperion Therapeutics, and clinical research positions at Eli Lilly and Company. He is also a member of several nonprofit and for-profits scientific advisory boards and is on the board of directors of EnBiotix, Inc. Dr. Hartman received his bachelor’s degree from Calvin College and his medical degree from Wayne State University. He trained in internal medicine and completed a fellowship in pulmonary medicine at Indiana University where he also was chief medical resident.
Clarion Johnson, M.D., served as global medical director of ExxonMobil Corporation until his retirement in 2013. Currently, Dr. Johnson is a consultant to ExxonMobil, the Chair of the Joint Commission’s International and Resource Boards and a member of the Yale School of Public Health Leadership Council. He serves on several boards including the Bon Secours Hospital System; the Advisory Board of the Yale School of Public Health; the Board on Global Health of the U.S. National Academies of Sciences, Engineering, and Medicine, and co-chairs its Forum on Public–Private Partnerships for Global Health and Safety. Dr. Johnson also has an HHS Secretary appointment to the National Institute of Occupational Safety and Health Advisory Board and was a member of the Virginia governor’s Task Force on Health reform and co-chair of the Insurance Reform Task Force. He is the past chair of Virginia Health Care Foundation, and the Board of City Lights Charter School in Washington, DC. He served as advisor and lecturer in the Harvard Medical School’s department of continuing education “Global Clinic Course” from 2005 to 2008. In 2013 he received the President’s Award from the Oil and International Petroleum
Industry Environment Conservation Association (IPIECA) and Oil and Gas Producers (OGP) for contributions to health, and in 2012, he was the recipient of the Society of Petroleum Engineers Award for Health, Safety, Security, Environment, and Social Responsibility. In 2011, he received a medal from the French Army’s Institute De Recherche Biomedical for “Project Tetrapole,” a public–private partnership in malaria research. Dr. Johnson is a graduate of Sarah Lawrence College and member of its board of trustees, and the Yale School of Medicine. While on active duty in the U.S. Army, he also trained as a microwave researcher at Walter Reed Army Institute of Research. He is board certified in internal medicine, cardiology, and occupational medicine.
Maureen Kamene Kimenye, M.B.B.S., joined the National Tuberculosis, Leprosy and Lung Disease Program (NTLD) Program in 2009 as the National Programmatic Management of Drug Resistant TB (PMDT) coordinator. She was later promoted to head the Care and Support Section where she was tasked with improving the quality of care given to all tuberculosis (TB), leprosy, and lung disease patients. Dr. Kamene Kimenye is currently the program’s deputy head and Multi-DrugResistant Tuberculosis (MDR TB) Program manager. She is also the manager of the TIBU project and TB ECHO project. She has a special interest in electronic health information systems and program management. Dr. Kamene Kimenye holds a medical degree from Moi University, Kenya, and a Partners in Health fellowship on MDR TB and HIV, Lesotho, and is currently pursuing a master’s degree in Public Health at the Jomo Kenyatta University of Agriculture and Technology (JKUAT), Kenya, and a master’s degree in business administration, management at University of Nicosia, Cyprus. She is a seasoned doctor with more than 10 years of experience in the medical field. She previously served as a medical doctor at Nyeri Provincial General Hospital in Kenya and as a Provincial AIDS and sexually transmitted infections coordinator in Central Province. As a medical doctor, she gained firsthand experience of how TB adversely affects patients, their families, communities, and the nation as a whole. Dr. Kamene Kimenye comes with a wealth of experience in MDR TB, electronic health information systems, ART, and TB management, and is keen to see Kenya attain zero TB, zero discrimination, and zero deaths due to TB. As the deputy head of the NTLD-Program, she steers the program to mainly focus on finding all cases of TB, making sure those with TB are treated and ensuring that all counties in Kenya have access to the latest tools and technologies in laboratories and diagnostics.
Margaret Kigozi, M.B.Ch.B., is a fellow of the Africa Leadership Initiative of the Aspen Institute. She is a trustee of the Shell Foundation. Dr. Kigozi
is a medical doctor by training who practiced medicine in Uganda, Kenya, and Zambia. She joined the corporate world in 1994 as marketing director of Crown Bottlers (Pepsi) Ltd. The company is now a market leader in the beverage sector. Six years later the government appointed her the Executive Director of Uganda Investment Authority. During her tenure as Executive Director Uganda received $4 billion foreign investment and licensed $10 billion domestic investors. Having retired from government in 2011, Dr. Kigozi has consulted with the United Nations Industrial Development Organization (UNIDO) and the International Trade Commission (ITC). Dr. Kigozi grows food on the family Zuri Model Farm in Kyasa. She is an ardent tree planter with pine and eucalyptus plantations. Her newest venture is an Echo Lodge on an Island in Lake Victoria. Dr. Kigozi sits on the advisory board of the apex private-sector association Private Sector Foundation Uganda. She is a board member of Uganda Manufacturers Association where she chairs the Marketing Committee, which hosts the prestigious Uganda International Trade Fair. She is president of Business and Professional Women Uganda. Dr. Kigozi sits on a number of boards and works with many organizations that support leadership and entrepreneurship for women and youth.
Rich Lamporte, MURP, joined Jhpiego as director of new program development in 2007, and brings 23 years of international development experience along with field assignments in 20 countries across 3 continents. Mr. Lamporte provides strategic leadership for the development of new programs. During his tenure, Jhpiego’s sponsored portfolio has increased six times above the 2007 level, including expansion of Jhpiego’s work in maternal and newborn health, family planning, HIV/AIDS, point-of-care service integration, and related innovations. During his tenure, public–private partnerships have expanded eightfold. Mr. Lamporte serves as the home office lead for urban health, a growing program area. Mr. Lamporte previously served as Vice President for Development at Partners of the Americas. There he developed new programs related to good governance, economic development, community mobilization, sports and youth development, cultural exchange, and education. He played a pivotal role in expanding business development opportunities through the advancement of multilateral partnerships, such as the Inter-American Development Bank’s Multilateral Investment Fund, and doubled individual fundraising. Mr. Lamporte began at Partners managing income-generating projects throughout Latin America and the Caribbean. Mr. Lamporte has served as a sustainable development and urban planning consultant for both UN Habitat and the Inter-American Development Bank. Mr. Lamporte began his career in Chile, where he served in the Peace Corps’ pioneer municipal management program, developing one of the country’s first
participatory development plans in the locality of Lautaro. Mr. Lamporte is a board member of Team River Runner, which promotes health and healing of wounded veterans through boating. An Eagle Scout and former emergency medical technician, he earned a master’s in urban and regional planning with a specialization in international development from Virginia Polytechnic Institute and State University.
Roger Magnusson, Ph.D., is professor of health law and governance at Sydney Law School, University of Sydney, Australia. He is also adjunct professor of law at Georgetown University Law Center in Washington, DC. His research interests are in health care law, public health law and governance, global health, and health development. Dr. Magnusson is known internationally for his work in public health law, particularly in the development of legal and regulatory responses to noncommunicable diseases. He was the co-chair of the Ad Hoc Working Group on Implementation, Monitoring, and Accountability for the World Health Organization’s Commission on Ending Childhood Obesity (2014–2015). He is the lead author of a report titled Advancing the Right to Health: The Vital Role of Law (published in 2017), undertaken with colleagues at the International Development Law Organization, the World Health Organization, and the O’Neill Institute for National and Global Health Law at Georgetown University. This report promotes the role of law in health development and seeks to assist low- and middle-income countries in the process of reforming their public health laws.
Benjamin Makai leads the social innovation unit at Safaricom Ltd., which works with like-minded organizations to form partnerships aimed at identifying issues and finding solutions in areas such as health, agriculture, education, and disaster management. He is responsible for building and maintaining winning partnerships with ecosystem industry stakeholders. Mr. Makai has a B.Sc. in computer science from Egerton University, various developing leadership capabilities training from Strathmore Business School, and was recently awarded a certificate of completion for the Rethinking Financial Inclusion Program from Harvard Business School.
Mark Malloch-Brown is co-chair of the Business and Sustainable Development Commission. He is a former Deputy Secretary-General of the United Nations as well as a previous administrator of the United Nations Development Programme (UNDP). He has also served in the British Cabinet and Foreign Office. He is active both in business and in the nonprofit world. He also remains deeply involved in international affairs.
Katherine Maloney, M.A., is a senior advisor to the United Nations Global Account Team at KPMG LLP and is a member of the Development and Exempt Organizations (DEO) Practice based in New York. In this capacity, she manages strategic advisory engagements at the intersection of international development and global philanthropy and builds client relationships with the United Nations (UN), private foundations, nongovernmental organizations (NGOs), multilateral development donors, and the public sector to advance effective solutions for inclusive and resilience economies. In 2013, Ms. Maloney spent 1 year on secondment to the World Economic Forum where she co-authored a report, The Future Role of Civil Society, which explores the evolving nexus between business, civil society, governments, and the resulting opportunities for constructive collaboration and partnership to address global societal challenges. Her particular interests include the power of business to shape achievement of the Sustainable Development Goals (SDGs), children and youth, global hunger and food security, and women and girl’s empowerment. Ms. Maloney’s first years at KPMG were spent within the Global Infrastructure practice in London, advancing public–private partnerships for social sector and transportation assets across the United Kingdom. Previously she worked at the U.S. Trade and Development Agency in Washington, DC, with a focus on Mexico and Central America, as well as on Capitol Hill for the Senate Foreign Relations Committee. She received her bachelor of arts in Spanish with a minor in political science from Wake Forest University and a master’s in international economics with a focus on Latin America from the Johns Hopkins University School of Advanced International Studies. Ms. Maloney is a board member of Mary’s Meals, USA, a global nonprofit committed to providing meals for children in school across 13 countries and a Global Give Back Circle mentor.
Marcel Mballa-Ekobena is the former executive head of Investment Products of East Africa at Standard Bank Group where he built the group’s Equity Investment Research platform for East Africa, one of the strongest franchises in sub-Saharan Africa. He has covered both developed and emerging markets banks and insurers as financial analyst at HSBC Investment Banking Research and at the World Bank’s International Finance Corporation (IFC) and J.P. Morgan Asset Management. Mr. Mballa-Ekobena holds a master’s degree in international securities and investment banking from the University of Reading Henley Business School and the International Capital Market Association (ICMA) Centre.
Stuart Merkel, M.B.A., Jhpiego’s director of corporate and foundation partnerships, gives leadership to advancing and deepening Jhpiego’s collaborations with the private sector in pursuit of its mission. Mr. Merkel is
an experienced public health professional who is committed to designing and delivering innovative and effective programs that improve the health of communities in lower-source countries. He has designed, supported, and led a wide range of maternal health, malaria, HIV, family planning, and reproductive health programs in Africa and Asia. Mr. Merkel lived in Nairobi, Kenya, for more than 3 years supporting Jhpiego’s efforts to strengthen the delivery of health services, bring about technical policy change, and emphasize community engagement in public health. In particular, Mr. Merkel is passionate about improving the health of the urban poor, and is the author of several technical reports on urban health in Africa. Mr. Merkel has lived, worked, and traveled throughout Africa, as well as in Asia, Latin America, and the Central Pacific. Mr. Merkel joined Jhpiego in 2005 and is currently based in Baltimore, Maryland.
Hon. Ahmed Sheikh Mohamed worked with several nonstate actors (both local and international) in various capacities before joining the Mandera County Government as County Minister for public service and now health services. These organizations include Islamic African Relief agency as country medical coordinator; Oxfam GB supported program on peace building and conflict resolution; Tegla Loroupe peace foundation as chief executive officer; program manager with Pact Kenya/pact world’s peace in east and central Africa; Program manager/Ag Head of field mission American refugee committee in Sudan/Darfur.
Jane Mwangi, M.B.Ch.B., M.Sc., serves as branch chief for the Division of Global HIV/TB Laboratory at U.S. Centers for Disease Control and Prevention (CDC), Kenya. The Laboratory partners with Becton, Dickinson and Company (BD) in the Labs for Life public–private partnership. She has been at CDC Kenya since August 2014. Prior to joining the CDC Dr. Mwangi worked as a senior lecturer in hematology and blood transfusion at the University of Nairobi, Kenya.
David Nabarro, M.A., M.Sc., B.M., B.Ch., serves as special advisor of the Secretary-General on the 2030 Agenda for Sustainable Development and Climate Change. He works with governments and other stakeholders to galvanize action on implementation of both the 2030 and Climate Action agendas. He also oversees the Secretary-General’s special initiatives, including Every Woman Every Child, Global Pulse and Zero Hunger Challenge, and the United Nations (UN) Office for Partnerships. Dr. Nabarro has more than 30 years of experience in public health, nutrition, and development at country, regional and global levels, and has held positions in nongovernmental organizations, universities, national governments, and the UN system. Dr. Nabarro joined the UN system in 1999, leading
the Roll Back Malaria initiative at the World Health Organization. He was appointed as a World Health Organization (WHO) Executive Director in 2001 and led WHO’s Department for Health Action in Crises from 2003. Between 2005 and 2014 he served as the UN System’s Senior Coordinator for Avian and Pandemic Influenza. From 2009 to 2016, Dr. Nabarro was the Special Representative of the UN Secretary-General for Food Security and Nutrition. From September 2014 until December 2015 he was Special Envoy of the United Nations Secretary-General on Ebola, providing strategic and policy direction for the international response.
Geir O. Pedersen was appointed Permanent Representative of Norway to the United Nations in New York in September 2012. Ambassador Pedersen was previously Director General in the Norwegian Ministry of Foreign Affairs, Department for the United Nations, Peace and Humanitarian Affairs. He served as the Secretary-General Special Personal Representative and Special Coordinator for Lebanon at the level of Under-Secretary-General from April 2007 to February 2008. Ambassador Pedersen has also served as Director of Asia and Pacific Division in the Department of Political Affairs. Between November 1998 and March 2003, he served as the Norwegian Representative to the Palestinian Authority. From 1995 to 1998 he held different positions at the Norwegian Ministry of Foreign Affairs in Oslo, among them as Chief of Staff for the Norwegian Foreign Minister. Ambassador Pedersen has also served as a Norwegian diplomat in China and Germany. In 1993 he was a member of the Norwegian team to the secret Oslo negotiations that led to the signing of the Declaration of Principles and the mutual recognition between the Palestine Liberation Organization (PLO) and Israel.
Glenn Rockman started his career at J.P. Morgan, where he advised university, research institutes, charitable foundations, and other nonprofit organizations on a wide variety of financing activities for more than 10 years in the firm’s investment banking division. After working closely with the Bill & Melinda Gates Foundation to establish the Global Health Investment Fund (GHIF) as a new financing mechanism for drug, vaccine, and diagnostic product development, he left J.P. Morgan in 2014 to join the GHIF investment management team.
Alexander Schulze, Ph.D., M.A., is a sociologist with a postgraduate diploma in development cooperation. He has worked as a project assistant for the Swiss Agency for Development and Cooperation (SDC) in Ouagadougou, Burkina Faso, before he took over various positions such as Communication and Project Officer and Access Program and Research Manager at the Novartis Foundation in Basel. In 2014 he joined SDC as
an Advisor for Health Systems Strengthening and Financing. Since July 2016 he is acting as Co-Head of the division Global Programme Health at SDC. His areas of work include access to health care and medical products, social health protection, and health financing as well as health product research and development. Dr. Schulze is a member of the Advisory Council to the Global Health Lancet Commission on High-Quality Health Systems.
Nelson K. Sewankambo, M.B.Ch.B., M.Sc., M.Med., FRCP, LLD (HC), is former dean of Makerere University Medical School, Uganda, a past principal Makerere University College of Health Sciences and a professor of internal medicine. In the past 18 years he focused on advancement of medical education and research capacity development. He is a fellow and president of the Uganda National Academy of Sciences, a vice president of the Network of African Sciences Academies (NASAC), and vice president of the Accordia Global Health Foundation. Dr. Sewankambo trained at Makerere University as a medical doctor, specialized in internal medicine, and later graduated in clinical epidemiology at McMaster University in Canada. He received a fellowship of the Royal College of Physicians in London; an honorary doctorate from the Johns Hopkins Bloomberg School of Public Health; a Grand Silver Medal, Karolinska Institutet, Sweden; a doctor of laws, honoris causa, McMaster University; and honorary fellowship of London School of Hygiene and Tropical Medicine. Dr. Sewankambo is also an external affiliate of the U.S. National Academy of Medicine and a fellow of the African Academy of Sciences.
Mozammil Siddiqui, LLB, M.Sc., is based in Geneva and works in the Global Operational Partnerships team at Gavi, the Vaccine Alliance. He is focused on forging strategic partnerships with the private sector to address the main challenges in immunizing children in some of the world’s poorest countries with lifesaving vaccines. He manages a portfolio of projects and engagements, which include working with the UPS Foundation, the International Federation of Pharmaceutical Wholesalers Foundation, and Zipline. He also manages a pipeline of innovative projects through Gavi’s “INFUSE” platform, bringing them to scale by providing strategic guidance and partnering them with the private sector. Mr. Siddiqui has more than 15 years of experience working in professional services industry and in the development sector, having lived and worked in Bangladesh and Pakistan.
Kathleen H. Sienko, Ph.D., SM, is an Arthur F. Thurnau Professor, Miller Faculty Scholar, and associate professor of mechanical engineering and biomedical engineering at the University of Michigan (UM). She earned
her Ph.D. in 2007 in medical engineering and bioastronautics from the Harvard University–Massachusetts Institute of Technology (MIT) Division of Health Science and Technology, and holds an S.M. in aeronautics and astronautics from MIT and a B.S. in materials engineering from the University of Kentucky. She co-directs the UM Center for Socially Engaged Design (Insitu) and directs both the Global Health Design Initiative (GHDI) and the Sienko Research Group. She is the recipient of a National Science Foundation (NSF) CAREER (Faculty Early Career Development Program) award and several teaching awards including the UM Teaching Innovation Prize, UM Undergraduate Teaching Award, and UM Distinguished Professor Award. While at MIT, she was a winner of the MIT $50K Entrepreneurship Competition. Dr. Sienko has initiated several innovative global experiential project learning programs at the Department, College of Engineering, and University levels using an educational framework and activities focused on design ethnography and human-centered, context-centered, and cocreative design processes. Recognized as an emerging model for human- and context-centered design, the UM GHDI provides engineering and nonengineering students with opportunities to identify and define global health challenges and develop appropriate solutions.
Peter Singer, M.D., M.P.H., has dedicated the past decade to bringing innovation to tackling the health challenges of the world’s poorest people. He is well known around the world for his creative solutions to some of the most pressing global health challenges. Dr. Singer is chief executive officer of Grand Challenges Canada. He is also professor of medicine at University of Toronto, director at the Sandra Rotman Centre at University Health Network, and Foreign Secretary of the Canadian Academy of Health Sciences. In 2007, Dr. Singer received the Michael Smith Prize as Canada’s Health Researcher of the Year in Population Health and Health Services. In 2011, Dr. Singer was appointed an officer of the Order of Canada for his contributions to health research and bioethics, and for his dedication to improving health in developing countries. In 2014, he was named by the United Nations (UN) Secretary-General’s Office as co-chair of the Every Woman Every Child Innovation Working Group. Dr. Singer is a Fellow of the Royal Society of Canada, the Canadian Academy of Health Sciences, the U.S. National Academy of Medicine, and The Academy of Sciences for the Developing World (TWAS). Dr. Singer has published more than 300 articles and mentored hundreds of students and staff. He studied internal medicine at University of Toronto, medical ethics at University of Chicago, public health at Yale University, and management at Harvard Business School.
Beck Smith works for Save the Children UK as their private-sector and SDGs advisor. She leads the organization’s post-2015 group, comprising more than 100 staff in country offices all over the world with a focus on ensuring the effective implementation of the SDGs at regional, national, and international levels. Prior to working to working at Save, Ms. Smith was advisor to the Shadow Exchequer Secretary focusing on issues of tax and growth. In addition to her role at Save, Ms. Smith also lectures at Imperial College London on science, policy, and politics.
Alan Staple, M.Sc., is head of the Global Markets Team at the Clinton Health Access Initiative (CHAI) where he has worked for the past 7 years. He was formerly an executive in the drug development industry with a background in strategy consulting. The Global Markets Team focuses on both global- and national-level work by rapidly improving market dynamics for medicines and diagnostics; lowering prices for treatment; and accelerating access to lifesaving technologies. The team recently concluded global agreements reducing prices and expanding access to viral load testing for HIV patients, long-acting revisable contraceptives, and drugs such as sofosbuvir and daclatasvir for curing hepatitis C. CHAI was founded in 2002 with a transformational goal: help save the lives of millions living with HIV/AIDS in the developing world. CHAI employs 1,500 people working in 35 countries.
Susanne Stormer, M.A., is vice president, chief sustainability officer in the Danish-based health care company Novo Nordisk. Ms. Stormer joined the Novo Group in 2000 to ingrain the Triple Bottom Line principle in the business as the lens for decision making and a strong component of the corporate culture. She is adjunct professor of corporate sustainability at the Copenhagen Business School and serves on several external boards.
Frans Swanepoel, Ph.D., M.Sc. Agric., is a research professor with focus on future Africa at the Centre for Advancement of Scholarship at the University of Pretoria (UP), South Africa. He is former deputy vice-chancellor research and innovation, and professor at the Institute for Poverty, Land and Agrarian Studies (PLAAS) at the University of the Western Cape (UWC), South Africa. He holds an appointment as visiting fellow at the Institute for African Development (IAD) at Cornell University, USA. Dr. Swanepoel serves in various capacities, including as board member, and previously as vice-chairperson and acting chairperson, on the Board of the Agricultural Research Council (ARC) in South Africa—a ministerial appointment. He also serves as board member of the Bill & Melinda Gates Foundation–funded African Women in Agricultural Research and Development (AWARD) initiative based in Kenya; and the continental
Science Granting Councils Initiative funded by the UK Department for International Development and Canada’s International Development Research Centre. He is an accomplished scientific leader in South Africa and internationally, confirmed by his election during 2010 as a member of the Academy of Science of South Africa (ASSAf), and his appointment as senior Fulbright fellow at Cornell University, USA (2008–2009), respectively. He is the first South African who has been elected as a foreign fellow of the Ugandan National Academy of Sciences (UNAS). In 2016 Dr. Swanepoel was recognised for his significant contributions to capacity development in support of agricultural transformation and development in Africa during the fifth African Higher Education Week, organised by the Regional University Forum for Capacity Building in Agriculture (RUFORUM). RUFORUM is a network of 66 African universities. He was professor at five South African universities, and has lectured and held visiting appointments at a number of institutions in Africa and around the world. He obtained all his degrees with distinction. Dr. Swanepoel researched at Texas A&M University, USA, and University of the Free State, South Africa, for his Ph.D., and completed postdoctoral research in Australia. His research interests include smallholder agricultural production systems, agricultural research and innovation leadership, and partnerships and networking in Africa. He has published extensively, with more than 170 scientific journal articles, conference proceedings, book chapters and reports. Dr. Swanepoel has been chief-editor for three books, including his latest, Towards Impact and Resilience: Transformative Change in and Through Agricultural Education and Training in Sub-Saharan Africa by Cambridge Scholars Publishing, United Kingdom, in collaboration with IAD at Cornell University, USA. He has supervised/co-supervised more than 50 master’s and Ph.D. students to completion, and regularly acts as external examiner for master’s dissertations and doctoral theses at leading universities around the globe, including Cornell, USA; Ghent, Belgium; Western Australia, Perth; Nairobi, Kenya and Ghana, Legon, Accra. Dr. Swanepoel has been elected as chairperson of the program committee for the 3rd International Conference on Global Food Security to be hosted in South Africa during December 2017.
Allison Tummon Kamphuis, M.B.A., is the Children’s Safe Drinking Water (CSDW) program leader at Procter & Gamble Co. (P&G). She has been with P&G for 19 years and manages P&G’s efforts to provide safe drinking water in the developing world. She has an M.B.A. from Xavier University and a Bachelor of Science in Nursing from McMaster University in Canada. Ms. Tummon Kamphuis also has more than a decade of experience in research and development as she led clinical operations for global cardiac clinical trials for P&G Pharmaceuticals prior to joining
the CSDW Program in 2008. The focus of the P&G CSDW Program is to provide clean drinking water using the company’s innovative household water treatment product called P&G Purifier of Water (formerly known as PUR). P&G has partnered with a diverse network of more than 150 public, private, and nongovernmental organizations to raise awareness of the global water crisis and distribute water purification packets in more than 75 developing countries. P&G is committed to the long-term, not-for-profit provision of P&G Purifier of Water in an effort to reduce illness and death, particularly in children. Since the start of the initiative in 2004, more than 10 billion liters of clean drinking water have been delivered to children and families around the world. Ms. Tummon Kamphuis is a member of the Public–Private Partnership Group of the World Health Organizations (WHO)/UNICEF International Network on Household Water Treatment and Safe Storage, a Clinton Global Initiative Program Advisor, and is a frequent speaker on public–private partnerships and safe drinking water in the developing world.
Mary Lou Valdez, M.S., joined the U.S. Food and Drug Administration (FDA) as associate commissioner for international programs on January 4, 2009. FDA’s Office of International Programs (OIP) is the focal point for the agency’s international efforts, in close alignment with FDA program centers and offices. Ms. Valdez leads, manages and coordinates OIP’s 100 or so staff around the world, catalyzing FDA global engagement in collaboration with international health and regulatory partners, ministries of health and agriculture, other U.S. government agencies, industry, academia, multilateral organizations, and other relevant stakeholders. In addition to FDA headquarters, OIP staff is strategically located in Belgium, Chile, China, Costa Rica, India, Italy, Jordan, Mexico, South Africa, and the United Kingdom. Ms. Valdez has the degree of Master of Science in Management from the University of Maryland University College, and a Bachelor of Science in Biology from the University of Texas at El Paso. She is proficient in reading, writing, and speaking Spanish. Ms. Valdez came to FDA after serving for 18 years in the U.S. Department of Health and Human Services (HHS), where she was extensively involved in international health diplomacy. As the Deputy Director of the Office of Global Health Affairs (OGHA), from August 2003 to December 2008 Ms. Valdez led the development of U.S. policy positions on a wide range of complex public health issues, promulgated them within the governance processes of multilateral organizations, and conducted negotiations with other member governments that resulted in the successful acceptance of many of these positions within the larger international community. Ms. Valdez has extensive experience in hands-on negotiations and diplomacy also as a member of the U.S. government delegations to
meetings of the governing bodies of multilateral organizations, including the World Health Organization Executive Board and the World Health Assembly; the Executive Board of the United Nations (UN) Children’s Fund; the Pan American Health Organization’s Executive Committee, Directing Council, and Pan American Sanitary Conference; the Health Committee of the Organization of Economic Cooperation and Development; and UN special sessions and councils, including the UN Special Session for Children in 2002.
Rajeev Venkayya, M.D., is the president of the Global Vaccine Business Unit (VBU) of Takeda Pharmaceuticals. He is responsible for Takeda’s global vaccine business, including full profit and loss (P&L) responsibility for the longstanding business in Japan and a global research and development pipeline that includes vaccine candidates for dengue, zika, norovirus and polio. Prior to joining Takeda, Dr. Venkayya was the Director of Vaccine Delivery in the Global Health Program at the Bill & Melinda Gates Foundation where he worked closely with leadership at the World Health Organization, UNICEF, GAVI, and the Global Polio Eradication Initiative, and served on the GAVI Board. Dr. Venkayya was previously the Special Assistant to the President and Senior Director for Biodefense at the White House Homeland Security Council, a position he held until October 1, 2007. Appointed by President Bush in May 2005, he directed the development of policies to prevent, protect, and respond to bioterrorism and naturally occurring biological threats such as avian influenza and severe acute respiratory syndrome (SARS), as well as the medical consequences of weapons of mass destruction. He completed his undergraduate and medical school education in the 6-year B.S./M.D. program at the Northeastern Ohio Universities College of Medicine, where he was inducted into the Alpha Omega Alpha honorary medical society. He is a life member of the Council on Foreign Relations.
Juergen Voegele, Ph.D., a German national, was appointed Senior Director of the Agriculture Global Practice on May 29, 2014. At the time of his appointment, he was serving as Director for Agriculture and Environmental Services in the Bank’s Sustainable Development Network, a position he had held since 2008. Previously, he was Sector Manager for Agriculture in the Bank’s Europe and Central Asia region, a role he assumed following an assignment in Beijing as Principal Agricultural Specialist and Rural Sector Coordinator. Following his doctoral studies, which included a 3-year assignment in Western Samoa, Dr. Voegele consulted and undertook research for a number of agencies and locations, including Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH and the German Federal Ministry of Economic Cooperation and Development with assign-
ments in the Caribbean, China, Myanmar, Niger, the Pacific Islands, and Togo, among others. Dr. Voegele joined the World Bank in 1991 as a Young Professional. Career highlights include his leadership of the acclaimed Loess Plateau watershed management project in China, and managing a multisectoral team that disbursed more than $1 billion for 70 projects in response to the global avian influenza crisis. Those latter efforts were replicated during the 2008 global food crisis. Beyond his operational work at the Bank, Dr. Voegele has played a key role in shaping the global agenda on agriculture and food security. He studied at the University of Hohenheim, Germany, from where he received a Ph.D. in Agricultural Economics; a Master of Agricultural Engineering in Crop Production, Economics, and Extension Forestry; and a postgraduate degree in Phytomedicine.
Nand Wadhwani is a Founding Trustee of the Mother and Child Health and Education Trust and lives in Hong Kong. For two decades Mr. Wadhwani has been building a network of more than 20 websites that offer the knowledge mothers and fathers, teachers and students, doctors and village health workers, community leaders and the public need to know to keep children healthy, with a strong focus on promoting breastfeeding, safe motherhood and newborn health, preventing and treating diarrhea, and improving water, sanitation, and hygiene practices particularly in India where 20 percent of the world’s maternal and child deaths are concentrated and 40 percent of the world’s stunted children live. Mr. Wadhwani, a health education industry veteran, is presently implementing HealthPhone™, one of the Trust’s flagship initiatives, which offers access to more than 2,500 short educational health and nutrition videos, audio and text messages, in more than 75 languages and suitable for people who cannot read. The videos are preloaded on a memory card and inserted into mobile phones. HealthPhone works with many partners in collating this vast library of health videos sourced from a variety of organizations. Mr. Wadhwani is a passionate advocate for the power of knowledge to educate, motivate, empower, and inspire communities and particularly women to improve health practices for the benefit of children. He serves on the board of directors of the Child Health Foundation, the international advisory council of the World Alliance for Breastfeeding Action (WABA), and on the steering group of Healthcare Information For All (HIFA).
This page intentionally left blank.